Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

Zacks #1 Stocks on the Move 04/16/2014

Company Name Symbol %Change
IMMUNOGEN IN IMGN
13.59%
BITAUTO HOLD BITA
9.88%
INTERACTIVE IBKR
8.58%
NOAH HOLDING NOAH
5.12%
INTERNATIONA ICAGY
4.72%
Eli Lilly is Among the Companies in the Pharmaceuticals Industry With the Highest Free Cash Flow Per Share (LLY, ENDP, FRX)

Print Share

Dec 28, 2012 (Fast Lane via COMTEX) -- Below are the three companies in the Pharmaceuticals industry with the highest free cash flow per share. FCF/share is a valuable metric signaling a company's ability to facilitate growth in the business.Eli Lilly (NYSE:LLY) is highest with FCF per share of $5.89. Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products for humans and animals. The Company's products are sold in countries around the world. Eli Lilly's products include neuroscience products, endocrine products, anti-infectives, cardiovascular agents, oncology products, and animal health products. In the past 52 weeks, shares of Eli Lilly have traded between a low of $38.30 and a high of $53.99 and are now at $48.86, which is 28% above that low price. The 200-day and 50-day moving averages have moved 0.32% higher and 0.17% lower over the past week, respectively.

Endo Pharmaceuticals (NASDAQ:ENDP) is next with FCF per share of $5.51. Finishing up the top three is Forest Laboratories (NYSE:FRX), with FCF per share of $4.98. ---------------------------------------------------------------------------------------------

Financial News Network Online (FNNO) is a leading provider of digital financial news content for distribution on the web. You can count on FNNO to bring you the latest market news, earnings reports, analyst comments, economic data reports and more. Visit http://www.fnno.com today.

Copyright, Comtex News Network, Inc. 2012

Free Stock Analysis From Zacks

Includes Zacks Long-Term Recommendation and Target Price

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.